NKGen Biotech, Inc. SEC Filings

Filed On	Filing
02 Sep 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
17 Jul 2026	8-K: Entry into a Material Definitive Agreement
02 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
21 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
04 May 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
21 Apr 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
26 Feb 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
05 Feb 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
26 Jan 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
20 Jan 2026	10-Q
16 Jan 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
09 Jan 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
08 Oct 2025	10-K
29 Sep 2025	8-K: Entry into a Material Definitive Agreement
24 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
09 Sep 2025	8-K: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure
17 Jul 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
17 Jul 2025	25-NSE
16 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
20 Jun 2025	8-K: Other Events

Comments